Presentation TCT 2025 TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial Presenter: Hyun-Jong Lee October 28, 2025
Presentation TCT 2025 TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation Presenter: Jinying Zhou October 28, 2025
Presentation TCT 2025 TCT 159: Effect of Evolocumab on coronary segments with calcified nodules: Insights from the YELLOW III study Presenter: Pruthvi C. Revaiah October 26, 2025
Presentation TCT 2025 Effect of EVOlocumab on Infarct Size in Patients with STEMI: The Prospective, Randomized, Open-Label EVO-STEMI Study Presenter: Hyun-Jong Lee October 25, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025
News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Daily News Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care Michael O'Riordan February 27, 2025
News Daily News Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab Michael O'Riordan February 05, 2025